RSS   Newsletter   Contact   Advertise with us
Post Online Media

Arrowhead Research to fire CSO David Lewis

Arrowhead ResearchArrowhead Research, a biotechnology company, notified David Lewis, the company’'s chief scientific officer, that his position will be terminated on December 13, 2016.
Article continues below

READ MORE Arrowhead Research adds Mauro Ferrari to the board of directors

Dr. Lewis, Chief Scientific Officer, has served in this role since September 2013. From October 2011 until September 2013, he served as the Company’s Vice President, Biology.

Dr. Lewis has served as Site Head for the Company’s Research and Development facility in Madison, Wisconsin since 2011 and prior to that as Site Head for the facility under Roche ownership from 2008 until 2011.

Dr. Lewis is a pioneer in the use of RNAi and was the first to show that siRNAs could be used to inhibit gene expression in multiple tissues of adult mammals.

Dr. Lewis received his B.S. degree in Biochemistry and Molecular Biology from the University of Wisconsin-Madison, and his Ph.D. degree in Biochemistry from Michigan State University.

Dr. Lewis went on to the Howard Hughes Medical Institute at the University of Wisconsin-Madison to perform post-doctoral studies.

He has authored 25 scientific papers and book chapters, has 19 patents, and has been awarded government-sponsored research grants totaling more than $5 million.

 LATEST MOVES FROM California 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy